Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Henrik S. Rasmussen Md currently holds 98,550 shares of NABI BIOPHARMACEUTICALS (NABI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Henrik S. Rasmussen Md has been a net seller of NABI stock. They have purchased $0 and sold $13.1M worth of shares.
Henrik S. Rasmussen Md's most recent insider trade was on Jun 4, 2021, when they sold 2,435 shares at $89.60 per share.
Henrik S. Rasmussen Md serves as Executive at NABI BIOPHARMACEUTICALS (NABI). They have executed 25 insider transactions totaling $13.1M over their tenure at the company.
Henrik S. Rasmussen Md holds the position of Executive at NABI BIOPHARMACEUTICALS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Henrik S. Rasmussen Md has shown a selling trading pattern, with $0 in total purchases and $13.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Henrik S. Rasmussen Md was on Mar 1, 2021, when they sold $2.4M worth of ALLK shares. This transaction involved 20,000 shares at $120.66 per share.
Henrik S. Rasmussen Md currently owns 98,550 shares of NABI BIOPHARMACEUTICALS (NABI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Henrik S. Rasmussen Md's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Henrik S. Rasmussen Md has 25 Form 4 filings on record as an insider at NABI BIOPHARMACEUTICALS.
Set alerts for Henrik S. Rasmussen Md and 40,000+ other insiders.